2024-2033 Macular Edema and Macular Degeneration Market Outlook: Unlocking Growth Potential
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Macular Edema and Macular Degeneration Market from 2024 to 2033?
The macular edema and macular degeneration market has grown robustly, projected to increase from $8.84 billion in 2023 to $9.65 billion in 2024 at a CAGR of 9.1%. Growth is driven by an aging population, the prevalence of diabetes, early diagnosis, eye health initiatives, and pharmaceutical advances.
The macular edema and macular degeneration market is expected to reach $12.84 billion by 2028, with a CAGR of 7.4%. Growth is driven by personalized medicine, increased awareness in emerging markets, focus on combination therapies, integration with teleophthalmology services, and the global aging population. Key trends include sustained-release drug delivery, gene therapy integration, novel imaging technologies, personalized treatment based on biomarkers, teleophthalmology for remote monitoring, and advancements in AI for diagnostics.
Claim Your Free Sample of the Global Macular Edema and Macular Degeneration Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13479&type=smp
What Key Factors Are Fueling the Growth of the Macular Edema and Macular Degeneration Market?
The rising diabetes population is driving the growth of the macular edema and macular degeneration market. Diabetes damages blood vessels in the eye, leading to conditions like macular edema and macular degeneration. The British Diabetic Association reported in April 2023 that over 5 million people in the UK are living with diabetes, and the number of those at high risk of type 2 diabetes continues to rise. This growing diabetic population is expected to increase the demand for treatments in the macular edema and macular degeneration market.
What Are the Major Segments of the Macular Edema and Macular Degeneration Market?
1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users
What New Trends Are Transforming the Macular Edema and Macular Degeneration Market?
Companies in the macular edema and macular degeneration market are focusing on innovative treatments like Vabysmo (faricimab-svoa) to boost their market share. In January 2022, Genentech received FDA approval for Vabysmo, a bispecific antibody used to treat neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). This groundbreaking treatment targets both vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2), making it a promising new option for patients with these eye conditions.
Order Now for Fast Delivery of Your Macular Edema and Macular Degeneration Market Report!
Which Regions Are Driving Growth in the Macular Edema and Macular Degeneration Market?
North America was the largest region in the macular edema and macular degeneration market market in 2023. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Macular Edema and Macular Degeneration Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the macular edema and macular degeneration market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Macular Edema and Macular Degeneration Market Include
1. Macular Edema and Macular Degeneration Market Executive Summary
2. Macular Edema and Macular Degeneration Market Segments
3. Macular Edema and Macular Degeneration Market Size And Template Market Growth Rate
4. Key Macular Edema and Macular Degeneration Market Trends
5. Major Macular Edema and Macular Degeneration Market Drivers
……
25. Key Mergers And Acquisitions In The Macular Edema and Macular Degeneration Market
26. Top Macular Edema and Macular Degeneration Companies
27. Macular Edema and Macular Degeneration Market Opportunities And Strategies
28. Macular Edema and Macular Degeneration Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Age-Related Macular Degeneration Global Market Report 2024
Macular Degeneration Treatment Global Market Report 2024
Alopecia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
